Impact of COVID-19 On Gastrointestinal Drugs Market Analysis, Size, Share, Growth, Trends - Global Forecast to 2023 Major Key Players Takeda Pharmaceticals; Allergan Plc; Novo Nordisk A/S; AstraZeneca Plc; Johnson & Johnson

The Business Research Company offers " Gastrointestinal Drugs Global Market Report 2020-30: COVID-19 Implications And Growth" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market's historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

The global gastrointestinal drugs market is expected to grow from $42.8 billion in 2019 to $48.5 billion in 2020 at a compound annual growth rate (CAGR) of 13.4%. The growth is mainly due to the impact of COVID-19 on digestive system. The digestive system manifestations in patients with COVID-19 include poor appetite, nausea, vomiting, diarrhea, abnormal liver enzymes, abdominal pain, and gastrointestinal bleeding. Patients with pre-existing digestive diseases such as inflammatory bowel disease may complain about exacerbation of symptoms or disease activity. The market is then expected to stabilize and grow at a CAGR of 4% from 2021 and reach $55.4 billion in 2023.

Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2136

The gastrointestinal drugs market consists of sales of gastrointestinal drugs and related services by entities (organizations, sole traders and partnerships) that produce gastrointestinal drugs to treat gastrointestinal diseases. This industry includes establishments that produce drugs such as antacids to treat acid reflux, indigestion and others, antiulcerants drugs to treat intestinal ulcers, antiobesity drugs and antiemetics drugs. It also consists of establishments which produce essential nutrients such as vitamins and mineral supplements.

Drug manufacturing companies are offering tranexamic acid for the treatment of acute gastrointestinal bleeding. Tranexamic acid is a medication used to treat or prevent excessive blood loss from major trauma or surgery and is now finding applications for gastrointestinal diseases. Tranexamic acid reduces clot breakdown, thus reducing the duration and amount of bleeding. This reduces mortality rate (from 10% to 7.5%) and the probability of blood transfusion by about 30%. Major companies manufacturing tranexamic acid include Abbott Laboratories, Pfizer, GlaxoSmithKline and Bayer AG.

Gastrointestinal Drugs Market Segmentation: -
By Type
Antacids
Antiulcerants
Vitamin And Minerals
Antiobesity
Antiemetics And Antinauseants
Antidiarrhoeals

By Distribution Channel
Hospital Pharmacies
Retail Pharmacies/ Drug Stores
Others

By Route Of Administration
Oral
Parenteral
Others

By Drug Classification
Branded Drugs
Generic Drugs

By Mode Of Purchase
Prescription-Based Drugs
Over-The-Counter Drugs

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/gastrointestinal-drugs-global-market-report-2020-30-covid-19-implications-and-growth

Few Points From Table Of Content
1. Executive Summary
2. Report Structure
3. Gastrointestinal Drugs Market Characteristics
4. Gastrointestinal Drugs Market Product Analysis
5. Gastrointestinal Drugs Market Supply Chain
......
20. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market
21. Market Background: Pharmaceutical Drugs Market
22. Recommendations
23. Appendix
24. Copyright And Disclaimer

The report covers the trends and market dynamics of the Gastrointestinal Drugs Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2136&type=smp

Some of the key players involved in the Gastrointestinal Drugs Market are Takeda Pharmaceticals; Allergan Plc; Novo Nordisk A/S; AstraZeneca Plc; Johnson & Johnson

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.